Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry.
Early interactions of herpes simplex virus type-1 (HSV-1) with cells lead to cytoskeletal changes facilitating filopodia formation and membrane fusion. Here, we demonstrate that phosphoinositide 3 kinase (PI3K) signalling may affect multiple steps during HSV-1 entry. An inhibitor of PI3K (LY294002) blocked HSV-1 entry and the blockage was cell-type- and gD receptor-independent. Entry inhibition was also observed with primary cultures of the human corneal fibroblasts and unrelated β- and γ-herpesviruses. Immunofluorescence analysis demonstrated that LY294002 negatively affected HSV-1-induced filopodia formation. Similar effects of the inhibitor were seen on HSV-1 glycoprotein-induced cell-to-cell fusion. Cells expressing HSV-1 glycoproteins (gB, gD, gH and gL) showed significantly less fusion with target cells in the presence of the inhibitor. Expression of a dominant-negative PI3K mutant negatively affected both entry and fusion. We also show that inhibition of PI3K signalling also affected RhoA activation required for HSV-1 entry into certain cell types.
Tiwari
Vaibhav
V
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
Shukla
Deepak
D
D002459:Cell Fusion; D002478:Cells, Cultured; D002867:Chromones / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000378:metabolism; D005347:Fibroblasts / Q000821:virology; D018259:Herpesvirus 1, Human / Q000502:physiology*; D006801:Humans; D008856:Microscopy, Fluorescence; D009025:Morpholines / Q000378:metabolism; D015388:Organelles / Q000187:drug effects; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D015398:Signal Transduction; D053586:Virus Internalization
D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Curr Top Microbiol Immunol. 2005;285:1-23
15609499
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4026-35
18502984
Mol Biol Cell. 2006 Sep;17(9):3940-51
16822839
Mol Cell Biol. 2000 Nov;20(21):8035-46
11027274
J Virol. 2000 Apr;74(8):3909-17
10729168
Curr Top Microbiol Immunol. 2005;285:67-108
15609501
Nat Rev Microbiol. 2004 Feb;2(2):109-22
15043007
Arch Ophthalmol. 1989 Aug;107(8):1155-9
2787981
Cell Mol Life Sci. 2002 Apr;59(4):608-26
12022470
Science. 1995 Aug 4;269(5224):690-3
7624799
Clin Infect Dis. 1998 Mar;26(3):541-53; quiz 554-5
9524821
Virology. 2010 Feb 20;397(2):389-98
20004926
Virology. 2000 Sep 15;275(1):1-8
11017782
J Virol. 2005 Oct;79(20):13173-9
16189018
FEBS J. 2008 Nov;275(21):5272-85
18803666
Cell. 1999 Oct 1;99(1):13-22
10520990
FEBS Lett. 2007 Sep 18;581(23):4468-72
17765228
Virus Res. 2001 Apr;74(1-2):39-45
11226572
Virology. 2008 Nov 10;381(1):16-21
18834609
J Virol. 2006 Dec;80(23):11432-46
17005646
Virol Sin. 2008 Dec 1;23(6):383-393
19956628
Curr Biol. 1999 May 20;9(10):512-21
10339426
J Gen Virol. 2004 Apr;85(Pt 4):775-786
15039520
J Gen Virol. 2004 Apr;85(Pt 4):805-809
15039523
Mol Cell Biol. 1999 Jun;19(6):4279-88
10330169
Curr Eye Res. 2010 Jun;35(6):445-50
20465436
J Biol Chem. 1993 May 5;268(13):9478-83
7683653
J Virol. 2006 Sep;80(18):8970-80
16940509
J Gen Virol. 2000 Aug;81(Pt 8):2017-2027
10900041
Virology. 2006 Mar 15;346(2):452-9
16336986
Cell Microbiol. 2006 Nov;8(11):1803-11
16869831
J Gen Virol. 2001 Jun;82(Pt 6):1419-1422
11369886
FEBS J. 2009 Dec;276(24):7228-36
19878306
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2878-87
19234349
J Biol Chem. 2009 Oct 23;284(43):29654-65
19726670
Cell. 1991 Apr 5;65(1):83-90
1849461
Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):341-7
16932027
J Virol. 1998 Jan;72(1):873-5
9420303
Cell. 2006 Feb 24;124(4):729-40
16497584
Mol Cell Biol. 1997 Aug;17(8):4406-18
9234699
J Cell Biol. 2006 Sep 25;174(7):1009-21
17000878
Virology. 2001 Jan 5;279(1):313-24
11145912
Cell. 2008 Mar 21;132(6):935-44
18358807
J Cell Biol. 2005 Jul 18;170(2):317-25
16027225
Cell. 2006 Feb 24;124(4):741-54
16497585
Virology. 1994 Feb 15;199(1):67-80
8116256
J Biomed Sci. 2005 Dec;12(6):881-98
16228294
J Virol. 2004 Jul;78(14):7508-17
15220424
Biochem Biophys Res Commun. 2005 Dec 16;338(2):930-7
16259945
J Virol. 2003 Feb;77(4):2539-49
12551992
J Clin Invest. 2001 Aug;108(4):503-10
11518721
Cell. 1996 Nov 1;87(3):427-36
8898196
Biochem J. 2005 Jan 15;385(Pt 2):451-9
15303968
Cell. 1992 Aug 7;70(3):419-29
1322797
Biochem J. 1998 Oct 1;335 ( Pt 1):1-13
9742206
Biochem Biophys Res Commun. 2010 Jan 1;391(1):176-81
19909728
Nat Cell Biol. 2007 Mar;9(3):310-5
17293854
Cell Microbiol. 2006 Mar;8(3):387-400
16469052
Cornea. 2001 Jan;20(1):1-13
11188989
J Biol Chem. 2002 Oct 4;277(40):37912-9
12138164
J Virol. 1998 Dec;72(12):9992-10002
9811737
Vision Res. 1981;21(1):41-3
7269289
J Virol. 1994 Nov;68(11):7586-90
7933147
J Virol. 1992 Jan;66(1):341-8
1309250